Filter News
Area of Research
News Type
News Topics
- (-) Neutron Science (2)
- 3-D Printing/Advanced Manufacturing (1)
- Artificial Intelligence (3)
- Biology (1)
- Biomedical (1)
- Buildings (1)
- Chemical Sciences (1)
- Climate Change (3)
- Computer Science (15)
- Coronavirus (2)
- Cybersecurity (2)
- Energy Storage (2)
- Environment (6)
- Frontier (3)
- High-Performance Computing (10)
- Machine Learning (1)
- Materials Science (3)
- Microscopy (2)
- Nanotechnology (1)
- National Security (1)
- Physics (1)
- Quantum Computing (5)
- Quantum Science (3)
- Security (1)
- Summit (5)
- Sustainable Energy (1)
- Transportation (1)
Media Contacts
![A material’s spins, depicted as red spheres, are probed by scattered neutrons. Applying an entanglement witness, such as the QFI calculation pictured, causes the neutrons to form a kind of quantum gauge. This gauge allows the researchers to distinguish between classical and quantum spin fluctuations. Credit: Nathan Armistead/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-11/Quantum%20Illustration%20V3_0.png?h=2e111cc1&itok=Bth5wkD4)
A team led by the U.S. Department of Energy’s Oak Ridge National Laboratory demonstrated the viability of a “quantum entanglement witness” capable of proving the presence of entanglement between magnetic particles, or spins, in a quantum material.
![An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-06/frame1.png?h=d1cb525d&itok=51pwBWyP)
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.